alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Part 3

#### Editorial Note:

Nomenclature changes to part 3 appear at 68 FR 14337, Mar. 25, 2003.

#### § 3.11 Documents which will be recorded.

(a) Assignments of applications, patents, and registrations, and other documents relating to interests in patent applications and patents, accompanied by completed cover sheets as specified in § 3.28 and § 3.31, will be recorded in the Office. Other documents, accompanied by completed cover sheets as specified in § 3.28 and § 3.31, affecting title to applications, patents, or registrations, will be recorded as provided in this part or at the discretion of the Director.

(b) Executive Order 9424 of February 18, 1944 (9 FR 1959, 3 CFR 1943-1948 Comp., p. 303) requires the several departments and other executive agencies of the Government, including Government-owned or Government-controlled corporations, to forward promptly to the Director for recording all licenses, assignments, or other interests of the Government in or under patents or patent applications. Assignments and other documents affecting title to patents or patent applications and documents not affecting title to patents or patent applications required by Executive Order 9424 to be filed will be recorded as provided in this part.

(c) A joint research agreement or an excerpt of a joint research agreement will also be recorded as provided in this part.

[62 FR 53202, Oct. 10, 1997, as amended at 70 FR 1824, Jan. 11, 2005; 70 FR 54267, Sept. 14, 2005; 78 FR 62408, Oct. 21, 2013]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
Order filed January 6, 2022 

In The

Fourteenth Court of Appeals

____________

NO. 14-21-00589-CV

____________

SYLVIA COOKE, Appellant

V.

RACHEL BAIER, Appellee

On Appeal from County Court at Law No. 2

Galveston County, Texas

Trial Court Cause No. CV-0087510

O R D E R

Appellant’s brief was due December 30, 20201. No brief or motion for 

extension of time has been filed. 

Unless appellant files a brief with this court on or before February 7, 2022, 

the court will dismiss the appeal for want of prosecution. See Tex. R. App. P. 

42.3(b). 

PER CURIAM

Panel Consists of Justices Jewell, Bourliot, and Poissant.
§ 205.21 Scope and purpose. ( a ) This subpart prescribes policies and procedures of the Copyright Office governing testimony, in legal proceedings in which the Office is not a party, by Office employees in their official capacities and the production of Office documents for use in legal proceedings pursuant to a demand, request, subpoena or order.
( b ) The purpose of this subpart is: ( 1 ) To conserve the time of Office employees for conducting official business;
( 2 ) To minimize the possibility of involving the Office in the matters of private parties or other issues which are not related to the mission of the Office;
( 3 ) To prevent the public from confusing personal opinions of Office employees with Office policy;
( 4 ) To avoid spending the time and money of the United States for private purposes;
( 5 ) To preserve the integrity of the administrative process, minimize disruption of the decision-making process, and prevent interference with the Office's administrative functions.
( c ) An employee of the Office may not voluntarily appear as a witness or voluntarily testify in a legal proceeding relating to his or her official capacity without proper authorization under this subpart.
( d ) This subpart does not apply to any legal proceeding in which: ( 1 ) An employee is to testify regarding facts or events that are unrelated to official business; or
( 2 ) A former employee is asked to testify as an expert on a matter in which that employee did not personally participate while at the Office so long as the former employee testifies concerning his or her personal opinion and does not purport to speak for or on behalf of the Copyright Office.
**Exhibit 31(b)**
**CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)**
I, Steven P. Kovac, certify that:
1. I have reviewed this report on Form 10-Q of Interphase Corporation(the “Company”); 2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary tomake the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered bythis report; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe Company as of, and for, the periods presented in this report; 4. The Company’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company andwe have:
(a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the Company, including itsconsolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is beingprepared;
(b) Evaluated the effectiveness of the Company’s disclosure controls andprocedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures as of the end of theperiod covered by this report based on such evaluation; and
(c) Disclosed in this report any change in the Company’s internal controlover financial reporting that occurred during the Company’s most recentfiscal quarter that has materially affected, or is reasonably likely tomaterially affect, the Company’s internal control over financial reporting;and
5. The Company’s other certifying officer and I have disclosed, based onour most recent evaluation of internal control over financial reporting,to the Company’s auditors and the Audit Committee of the Company’s Boardof Directors:
(a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the Company’s ability to record, process, summarizeand report financial information; and
(b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the Company’s internal control overfinancial reporting.
Date: May 13, 2004         Signature:        /s/ Steven P. Kovac        Chief Financial Officer
#### § 1.703 Percentage estimate.

It is the Department of Veterans Affairs objective that 20 percent of its first class official mail addressed to the public contain missing children photographs and information.

(Authority: 39 U.S.C. 3220(a)(2), 5 U.S.C. 301)

[60 FR 48388, Sept. 19, 1995]
H. R. 2011 

One Hundred Tenth Congress 

of the 

United States of America 

AT THE FIRST SESSION 

Begun and held at the City of Washington on Thursday, 

the fourth day of January, two thousand and seven 

An Act 

To designate the Federal building and United States courthouse located at 100 

East 8th Avenue in Pine Bluff, Arkansas, as the ‘‘George Howard, Jr. Federal 

Building and United States Courthouse’’. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. GEORGE HOWARD, JR. FEDERAL BUILDING AND UNITED 

STATES COURTHOUSE. 

(a) DESIGNATION.—The Federal building and United States 

courthouse located at 100 East 8th Avenue in Pine Bluff, Arkansas, 

shall be known and designated as the ‘‘George Howard, Jr. Federal 

Building and United States Courthouse’’. 

(b) REFERENCES.—Any reference in a law, map, regulation, 

document, paper, or other record of the United States to the Federal 

building and United States courthouse referred to in subsection 

(a) shall be deemed to be a reference to the ‘‘George Howard, 

Jr. Federal Building and United States Courthouse’’. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
#### STATE of Louisiana ex rel. Jay A. VICTORIAN v. Frank C. BLACKBURN, Warden, Louisiana State Penitentiary.

No. 67306.

Supreme Court of Louisiana.

May 30, 1980.

In re Jay A. Victorian applying for writ of habeas corpus. Parish of East Baton Rouge. No. 7-74-2858.

Denied.
<TABLE> <S> <C>



<ARTICLE> 5
<LEGEND>

THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
UNAUDITED  FINANCIAL  STATEMENTS FOR THE NINE MONTH PERIOD ENDED MARCH 31, 2000,
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.

</LEGEND>


<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           5,400
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                  1,314,300
<CURRENT-ASSETS>                             1,319,700
<PP&E>                                       1,088,000
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               3,805,200
<CURRENT-LIABILITIES>                        3,039,900
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        39,700
<OTHER-SE>                                   (700,600)
<TOTAL-LIABILITY-AND-EQUITY>                 3,805,200
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               558,900
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             178,500
<INCOME-PRETAX>                              (775,100)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (775,100)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (775,100)
<EPS-BASIC>                                      (.02)
<EPS-DILUTED>                                        0




</TABLE>
#### § 16.124 Conditions.

With respect to any research project or any class of research projects the department or agency head of either the conducting or the supporting Federal department or agency may impose additional conditions prior to or at the time of approval when in the judgment of the department or agency head additional conditions are necessary for the protection of human subjects.
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.3 Business to be conducted with decorum and courtesy.

Applicants and their attorneys or agents are required to conduct their business with the United States Patent and Trademark Office with decorum and courtesy. Papers presented in violation of this requirement will be submitted to the Director and will not be entered. A notice of the non-entry of the paper will be provided. Complaints against examiners and other employees must be made in correspondence separate from other papers.

[68 FR 38624, June 30, 2003]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
#### Frank Nusbaum, Appellant, *v.*Adolph Weber, Respondent.

Appeal by the plaintiff from a judgment entered upon a verdict in his favor, and from an order denying a motion for a new-trial.

Kenneson, Crain & Ailing (Thomas C. T. Crain, of counsel)* for appellant.

Robert L. Redfield, for respondent.

*Per Curiam.*

Judgment and order appealed from affirmed* withcosts.

Present: Eitzsimohs, Ch. J., and O’Dwyeb, J.

Judgment and order affirmed, with costs.
#### § 11.81 Rediscounts with Federal Reserve Banks.

Upon the endorsement of any bank, which shall be deemed a waiver of demand, notice and protest by such bank as to its own endorsement exclusively, and subject to regulations to be prescribed by the Federal Reserve Board, any such note secured by an Adjusted Service Certificate and held by a bank is made eligible for discount or rediscount by the Federal reserve bank of the Federal reserve district in which such bank is located, whether or not the bank offering the note for discount or rediscount is a member of the Federal Reserve System and whether or not it acquired the note in the first instance from the veteran or acquired it by transfer upon the endorsement of any other bank: *Provided,* That at the time of discount or rediscount such note has a maturity not in excess of 9 months, exclusive of days of grace, and complies in all other respects with the provisions of the law, the regulations of the Federal Reserve Board and the regulations in this part.
Exhibit 32.2

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

UNDER

SECTION 906 OF THE SARBANES-OXLEY ACT

THE COAST
DISTRIBUTION SYSTEM, INC.

Quarterly Report on Form 10-Q

for
the Quarter and Six Months ended June 30, 2006

The undersigned, who is the Chief Financial Officer of The Coast Distribution System,
Inc. (the Company), hereby certifies that (i) the Quarterly Report on Form 10-Q for the quarter and six month period ended June 30, 2006, as filed by the Company with the Securities and Exchange Commission (the Quarterly
Report), to which this Certification is an Exhibit, fully complies with the applicable requirements of Section 13(a) and 15(d) of the Exchange Act; and (ii) the information contained in this Quarterly Report fairly presents, in all
material respects, the financial condition and results of operations of the Company.

Dated : August 14, 2006



/s/ SANDRA A. KNELLSandra A. KnellExecutive Vice President and Chief Financial OfficerA signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.925 Partial refund if request for *inter partes* reexamination is not ordered.

Where *inter partes* reexamination is not ordered, a refund of a portion of the fee for requesting *inter partes* reexamination will be made to the requester in accordance with § 1.26(c).

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack

, Chief Justice

David F. Viviano,

Chief Justice Pro Tem

Stephen J. Markman

Brian K. Zahra

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh,

Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

March 15 , 2019 

# Order

Clerk March 15 , 2019

15 8983 ( 41 )

JEREMY HOOKER,

Appellee,

v SC: 158983

COA: 343334

BRENDA M. MOORE,

Appellant

.

______________________________________ /

On order of the C hief Justice , the motion of the Michigan Association of County

Drain Commissioners , the Michigan Association of Counties, and the Michigan Townships

Association to file a brief amicus curiae is GRA NTED. The amicus brief submitted on

March 14, 201 9 , is accepted for filing

.
§ 493.1276 Standard: Clinical cytogenetics. ( a ) The laboratory must have policies and procedures for ensuring accurate and reliable patient specimen identification during the process of accessioning, cell preparation, photographing or other image reproduction technique, photographic printing, and reporting and storage of results, karyotypes, and photographs.
( b ) The laboratory must have records that document the following: ( 1 ) The media used, reactions observed, number of cells counted, number of cells karyotyped, number of chromosomes counted for each metaphase spread, and the quality of the banding.
( 2 ) The resolution is appropriate for the type of tissue or specimen and the type of study required based on the clinical information provided to the laboratory.
( 3 ) An adequate number of karyotypes are prepared for each patient.
( c ) Determination of sex must be performed by full chromosome analysis.
( d ) The laboratory report must include a summary and interpretation of the observations, number of cells counted and analyzed, and use the International System for Human Cytogenetic Nomenclature.
( e ) The laboratory must document all control procedures performed, as specified in this section.
[68 FR 3703, Jan. 24, 2003; 68 FR 50724, Aug. 22, 2003]
§ 440.335 Benchmark-equivalent health benefits coverage. ( a ) *Aggregate actuarial value.* Benchmark-equivalent coverage is health benefits coverage that has an aggregate actuarial value, as determined under § 440.340, that is at least actuarially equivalent to the coverage under one of the benchmark benefit packages described in § 440.330 for the identified Medicaid population to which it will be offered.
( b ) *Required coverage.* Benchmark-equivalent health benefits coverage must include coverage for the following categories of services: ( 1 ) Inpatient and outpatient hospital services.
( 2 ) Physicians' surgical and medical services.
( 3 ) Laboratory and x-ray services.
( 4 ) Well-baby and well-child care, including age-appropriate immunizations.
( 5 ) Emergency services.
( 6 ) Family planning services and supplies and other appropriate preventive services, as designated by the Secretary.
( 7 ) Prescription drugs.
( 8 ) Mental health benefits.
( c ) *Additional coverage.* ( 1 ) In addition to the types of benefits of this section, benchmark-equivalent coverage may include coverage for any additional benefits of the type which are covered in 1 or more of the standard benchmark coverage packages described in § 440.330(a) through (c) or State plan benefits, described in section 1905(a), 1915(i), 1915(j), 1915(k) and 1945 of the Act, any other Medicaid State plan benefits enacted under title XIX, or benefits available under base-benchmark plans described in 45 CFR 156.100.
( 2 ) If the benchmark coverage package used by the State for purposes of comparison in establishing the aggregate actuarial value of the benchmark-equivalent package includes any of the following four categories of services: Prescription drugs; mental health services; vision services; and hearing services; then the actuarial value of the coverage for each of these categories of service in the benchmark-equivalent coverage package must be at least 75 percent of the actuarial value of the coverage for that category of service in the benchmark plan used for comparison by the State.
[75 FR 23101, Apr. 30, 2010, as amended at 78 FR 42306, July 15, 2013]